Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next‐generation therapeutics
Abstract The eXchange Unit between Thiolation domains approach and artificial intelligence (AI)‐driven tools like Synthetic Intelligence are transforming nonribosomal peptide synthetase and polyketide synthase engineering, enabling the creation of novel bioactive compounds that address critical chal...
Saved in:
| Main Authors: | Emre F. Bülbül, Helge B. Bode, Steven Schmitt, Kenan A. J. Bozhüyük |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Synthetic Immunology for Targeted Treatment of Systemic Autoimmune Diseases: Opportunities, Challenges, and Future Directions
by: Galih Januar Adytia, et al.
Published: (2025-01-01) -
Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
by: Shun Huang, et al.
Published: (2025-08-01) -
Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine
by: Asiya Nazir, et al.
Published: (2024-12-01) -
The tiny giants of regeneration: MSC-derived extracellular vesicles as next-generation therapeutics
by: Tianhe Zhang, et al.
Published: (2025-07-01) -
Past, Present and Future Perspective of Artificial Intelligence in Healthcare and Nanotechnology: A Communication
by: Mansi Jain, et al.
Published: (2024-11-01)